BIOTISSUE's CryoTek Method: Mechanism of Action

Show Description +

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

Cornea

Corneal Disease

BIOTISSUE's CryoTek Method: Mechanism of Action

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

Cornea

Corneal Disease

Please log in to leave a comment.

More in Cornea

Use Your Dream Team to Execute Your Keratoconus Strategy

Brandon D. Ayres, MD; Susan DeGroot, MBA; and Vivian Cole, BA

Uveitic Pupilloplasty

Ariana Levin, MD, and Gabrielle Fridman, MD

Surgical Management of Surface Tumors

Carol Karp, MD; Cullen Ryburn, MD; and Noah Cohen, MD